03/20/2025
Exciting news from Anuncia! 📢📢📢
The Company has received Breakthrough Device Designation from the FDA for its ReFlow EVD (external ventricular drains) used to manage brain swelling and elevated intracranial pressure. Our growing portfolio of products is allowing us to now support neurocritical beyond our proven efforts in CSF management. 🎊🎊
Beyond our US based efforts, we are proud to support improved care in Africa with NeuroKids and have been granted funds from the prestigious Flinn Foundation to further our commitment to clinical research. 🌍🔬
We are so grateful to the neurosurgeons, nurses, patients and parents who support and inspire us to continue innovating. 👩🏽⚕️👨🏼⚕️👩🏾🍼👨🏻🍼🧑🧑🧒🧑🧒🧒
Please consider liking and resharing our news to support our growth.👍🏼📈
hashtag
/PRNewswire/ -- Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation...